Annual Review

2018: a year of
review on our
85th anniversary

Scroll for more

Our
purpose

is to provide efficient and accessible
medicines through continuing
innovation and sustainable development.

Letter to the
Shareholders

It's been a year of review - on our 85th anniversary, we looked back to enjoy our successes, to thank the people with whom we've achieved them and to celebrate with everyone we want to share our future with. Thank you for sharing!

Read more

Key indicators

Sopharma group

In 2018 SOPHARMA GROUP registered 16% growth in sales revenue

1179143

(+16%)

BGN '000 Revenues from sales

39143

(-30%)

BGN '000 Operating profit

72278

(-16%)

BGN '000 EBITDA

30637

(-33%)

BGN '000 Net profit

Sopharma AD

2018 was a year of reviewing and setting new targets

212418

(-3%)

BGN '000 Revenues from sales

27798

(-35%)

BGN '000 Operating profit

45212

(-26%)

BGN '000 EBITDA

33298

(-25%)

BGN '000 Net profit

Key financial indicators
Sopharma group

BGN '000 2018 2017 2016
Revenues from sales 1 179 143 1 017 105 877 085
EBITDA 72 278 85 944 73 656
Operating profit 39 143 55 836 44 951
Net profit 30 637 45 772 54 902
EBITDA/ sales revenues 6% 8% 8%
Operating profit/ sales revenues 3% 6% 5%
Net debt/ EBITDA an annual basis 4.1x 3.0x 2.8x
Attracted capital/ Equity 0.99 0.95 0.75

“Sopharma” AD

BGN '000 2018 2017 2016
Revenues from sales 212 418 219 079 182 396
EBITDA 45 212 61 313 43 849
Operating profit 27 798 42 866 28 363
Net profit 33 298 44 228 38 347
EBITDA/ sales revenues 21.30% 28% 24%
Operating profit/ sales revenues 13% 20% 16%
Net debt/ EBITDA an annual basis 1.6x 1.2x 1.61x
Attracted capital/ Equity 0.24 0.24 0.24

REVENUE BREAKDOWN BY SEGMENTS IN 2018

PORTFOLIO OF PRODUCTS BY THERAPEUTIC GROUPS IN 2018

GEOGRAPHICAL SPLIT IN 2018

Enviroment, Social activity and Managment

In order to ensure sustainable development, the Company works successfully on reducing its environmental footprint by adhering to good corporate governance practices, optimizing raw materials usage, utilizing waste, improving people's quality of life and providing excellent working conditions.

4895

EMPLOYEES IN 2017

743

DONATION IN 2017

BGN '000

5073

EMPLOYEES IN 2018

598

DONATION in 2018

BGN '000

Enviroment, Social activity and Managment

767575

REVENUES FROM SALES OF GOODS IN 2017

BGN ‘000

743

REVENUES FROM SALES OF PRODUCTS IN 2017

BGN ‘000

928334

REVENUES FROM SALES OF GOODS IN 2018

BGN ‘000 (+20.94%)

250809

REVENUES FROM SALES OF PRODUCTS IN 2018

BGN ‘000 (+0.51%)

Enviroment, Social activity and Managment

9%

OF REVENUES FROM SALES OF PRODUCTS IN 2017

RAW MATERIALS

8%

OF REVENUES FROM SALES OF PRODUCTS IN 2018

RAW MATERIALS

MANAGEMENT TEAM

44%

Women

56%

Men

PROFILE AND
STRATEGY OF
THE COMPANY

Established and reliable company
with 85 years of history

Values
& commitment

Our values

SHORT
OVERVIEW
OF 2018

“SOPHARMA” AD
on the stock
exchange

Download
center